Correlation Between Spyre Therapeutics and QBE Insurance
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and QBE Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and QBE Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and QBE Insurance Group, you can compare the effects of market volatilities on Spyre Therapeutics and QBE Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of QBE Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and QBE Insurance.
Diversification Opportunities for Spyre Therapeutics and QBE Insurance
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Spyre and QBE is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and QBE Insurance Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QBE Insurance Group and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with QBE Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QBE Insurance Group has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and QBE Insurance go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and QBE Insurance
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the QBE Insurance. In addition to that, Spyre Therapeutics is 1.47 times more volatile than QBE Insurance Group. It trades about -0.02 of its total potential returns per unit of risk. QBE Insurance Group is currently generating about 0.08 per unit of volatility. If you would invest 1,080 in QBE Insurance Group on August 29, 2024 and sell it today you would earn a total of 85.00 from holding QBE Insurance Group or generate 7.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 97.67% |
Values | Daily Returns |
Spyre Therapeutics vs. QBE Insurance Group
Performance |
Timeline |
Spyre Therapeutics |
QBE Insurance Group |
Spyre Therapeutics and QBE Insurance Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spyre Therapeutics and QBE Insurance
The main advantage of trading using opposite Spyre Therapeutics and QBE Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, QBE Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in QBE Insurance will offset losses from the drop in QBE Insurance's long position.Spyre Therapeutics vs. Bright Minds Biosciences | Spyre Therapeutics vs. HP Inc | Spyre Therapeutics vs. Intel | Spyre Therapeutics vs. Chevron Corp |
QBE Insurance vs. Progressive Corp | QBE Insurance vs. White Mountains Insurance | QBE Insurance vs. Chubb | QBE Insurance vs. W R Berkley |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |